Literature DB >> 1985006

Visceral perception in health and functional dyspepsia. Crossover study of gastric distension with placebo and domperidone.

M Bradette1, P Pare, P Douville, A Morin.   

Abstract

The symptoms of functional dyspepsia are still unexplained. To evaluate the possible role of abnormal visceral perception, we studied the symptomatic responses and the pressure variations during progressive gastric distension in 10 female healthy control subjects (mean age 33.6 years) and in 10 female patients with functional dyspepsia (mean age 35.2 years). A rubber balloon was positioned 4 cm below the lower esophageal sphincter (LES) and inflated with progressively larger volumes of air by steps of 50 ml; pressures at the gastric fundus and at the LES were continuously recorded by perfused manometric catheters. Each subject was studied on two separate occasions after randomized double-blind administration of either placebo or 20 mg of domperidone. Symptomatic responses and the manometric data were analyzed at the time of the initial recognition of distension (bloating step) and at the time of reporting pain or up to a maximum of 700 ml of balloon inflation (pain or 700-ml step). On placebo, the volumes of gastric distension were more than two times lower in patients than in control subjects at the bloating step (185 +/- 32 ml vs 470 +/- 40 ml, P = 0.001) and at the pain or 700-ml step (265 +/- 54 ml vs 600 +/- 34 ml, P less than 0.005), while the pressure gradients (pressure at inflation steps minus baseline pressure before beginning inflation) were not statistically different between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985006     DOI: 10.1007/bf01300087

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  21 in total

1.  Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials.

Authors:  G Dobrilla; M Comberlato; A Steele; P Vallaperta
Journal:  J Clin Gastroenterol       Date:  1989-04       Impact factor: 3.062

2.  Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice.

Authors:  J H Saunders; R J Oliver; D L Higson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

3.  Lack of association between gastric emptying of solids and symptoms in nonulcer dyspepsia.

Authors:  N J Talley; B Shuter; G McCrudden; M Jones; R Hoschl; D W Piper
Journal:  J Clin Gastroenterol       Date:  1989-12       Impact factor: 3.062

Review 4.  Functional dyspepsia. Symptoms and underlying mechanism.

Authors:  M Camilleri; D G Thompson; J R Malagelada
Journal:  J Clin Gastroenterol       Date:  1986-08       Impact factor: 3.062

5.  Manometric evaluation of functional upper gut symptoms.

Authors:  J R Malagelada; V Stanghellini
Journal:  Gastroenterology       Date:  1985-05       Impact factor: 22.682

6.  Major life event stress and dyspepsia of unknown cause: a case control study.

Authors:  N J Talley; D W Piper
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

Review 7.  Nonulcer dyspepsia.

Authors:  W G Thompson
Journal:  Can Med Assoc J       Date:  1984-03-01       Impact factor: 8.262

8.  Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome.

Authors:  J Ritchie
Journal:  Gut       Date:  1973-02       Impact factor: 23.059

9.  Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia. The irritable stomach syndrome.

Authors:  M Lémann; J P Dederding; B Flourié; C Franchisseur; J C Rambaud; R Jian
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

10.  Symptomatic, radionuclide and therapeutic assessment of chronic idiopathic dyspepsia. A double-blind placebo-controlled evaluation of cisapride.

Authors:  R Jian; F Ducrot; A Ruskone; S Chaussade; J C Rambaud; R Modigliani; J D Rain; J J Bernier
Journal:  Dig Dis Sci       Date:  1989-05       Impact factor: 3.199

View more
  50 in total

Review 1.  Spinal and supraspinal modulation of visceral sensation.

Authors:  E A Mayer
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Metoclopramide in the treatment of diabetic gastroparesis.

Authors:  Allen Lee; Braden Kuo
Journal:  Expert Rev Endocrinol Metab       Date:  2010

3.  Functional Dyspepsia: Impaired Fundic Accommodation.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-08

Review 4.  Sex and gender in irritable bowel syndrome.

Authors:  Shin Fukudo
Journal:  J Gastroenterol       Date:  2006-06       Impact factor: 7.527

5.  Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy.

Authors:  Manabu Ishii; Noriaki Manabe; Hiroaki Kusunoki; Tomoari Kamada; Motonori Sato; Hiroshi Imamura; Akiko Shiotani; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

6.  Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function.

Authors:  M Thumshirn; M Camilleri; S B Saslow; D E Williams; D D Burton; R B Hanson
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

7.  Nutrient-specific modulation of gastric mechanosensitivity in patients with functional dyspepsia.

Authors:  R Barbera; C Feinle; N W Read
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

8.  Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.

Authors:  J Arts; P Caenepeel; K Verbeke; J Tack
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

9.  Heightened visceral sensation in functional gastrointestinal disease is not site-specific. Evidence for a generalized disorder of gut sensitivity.

Authors:  K C Trimble; R Farouk; A Pryde; S Douglas; R C Heading
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

10.  Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone.

Authors:  M Bradette; M Delvaux; G Staumont; J Fioramonti; L Bueno; J Frexinos
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.